Weakness

RADICAVA ORS® (edaravone) Added to U.S. Department of Veterans Affairs National Formulary

Retrieved on: 
Friday, March 10, 2023
Edaravone, ALS, Formulary (pharmacy), History, Fatigue, Use, Average absolute deviation, Veteran, Headache, Hypersensitivity, U.S. Department of Veterans Affairs, Office of Inspector General, Bruise, Aes, Weakness, MTPA, ORS, Pharmacy, Criterion, Food, Yugyd Va National Park, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pharmaceutical industry, Birth control

JERSEY CITY, N.J., March 10, 2023 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is proud to announce that as of June 2022, RADICAVA ORS® (edaravone) has been added to the U.S. Department of Veterans Affairs National Formulary (VANF), with a national prior authorization process in place, making the treatment accessible to U.S. veterans living with amyotrophic lateral sclerosis (ALS) who are within the VA's integrated healthcare system.

Key Points: 
  • "Given the devastating nature of ALS and the demand for additional treatment options, we are thrilled to see RADICAVA ORS added to the VA's National Formulary," said Atsushi Fujimoto, President, MTPA.
  • "MTPA is committed to helping U.S. veterans living with ALS have access to our treatments, and we applaud the VA for making RADICAVA ORS available as an option for them."
  • The Criteria for Use of RADICAVA ORS can be found at the VA website here: https://www.pbm.va.gov/apps/VANationalFormulary/ .
  • RADICAVA and RADICAVA ORS are contraindicated in people with a history of hypersensitivity to edaravone or any of the inactive ingredients.1 See Important Safety Information below.

Airgain® Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, March 9, 2023
Technology, Mobile, Wireless, Hardware, Telecommunications, Acquisition, Advertising, GAAP, Wi-Fi, Weakness, Internet of things, EBITDA, HPUE, Video game, Pharmaceutical industry

Sales increased by 3.6%, or $0.7 million in the fourth quarter of 2022 compared to $19.2 million in the third quarter of 2022.

Key Points: 
  • Sales increased by 3.6%, or $0.7 million in the fourth quarter of 2022 compared to $19.2 million in the third quarter of 2022.
  • GAAP gross profit for the fourth quarter of 2022 was $5.9 million compared to $7.4 million for the third quarter of 2022 and $4.9 million in the same year-ago period.
  • GAAP gross margin for the fourth quarter of 2022 was 29.6%, compared to 38.8% for the third quarter of 2022 and 34.4% in the same year-ago period.
  • Operating expenses were higher for the fourth quarter of 2022 compared to the third quarter of 2022 due to higher professional services.

TD Ameritrade Investor Movement Index: IMX Score Continues to Rise in February

Retrieved on: 
Monday, March 6, 2023
Other Consumer, Finance, Fintech, Consulting, Banking, Millennials, Professional Services, Data Analytics, Consumer, Asset Management, Main Street, Bureau, Personal income, TD Ameritrade, Labour, CPI, Federal, Producer, Treasury, PCE, Reading, Name, PPI, Personal consumption expenditures price index, Federal funds rate, TD, CBOE, VIX, Multimedia, Weakness, IMX, FOMC, Fed, Cryptocurrency

The Investor Movement Index ® (IMX℠) increased to 4.57 in February, up from its score of 4.31 in January.

Key Points: 
  • The Investor Movement Index ® (IMX℠) increased to 4.57 in February, up from its score of 4.31 in January.
  • The IMX is TD Ameritrade’s proprietary, behavior-based index, aggregating Main Street investor positions and activity to measure what investors actually were doing and how they were positioned in the markets.
  • View the full release here: https://www.businesswire.com/news/home/20230306005191/en/
    The reading for the four-week period ending February 24, 2023 ranks “moderate low” compared to historic averages.
  • “For the first time since September ’22, TD Ameritrade clients were net buyers of equities,” said Shawn Cruz, head trading strategist, TD Ameritrade.

AdventHealth Opens Dedicated Heart Failure Unit to Provide More Advanced Monitoring to Patients

Retrieved on: 
Wednesday, March 8, 2023
Cardiology, Physician, AdventHealth, American Heart Association, Swelling, Wheeze, Nausea, DRS, Heart, Quality of life, Health, Patient, Disease, Heart failure, Weakness, Conditional sentence, Appetite, Dizziness, Jamia, Medical imaging, Medical device, Greater Tampa Bay Area Council

TAMPA, Fla., March 8, 2023 /PRNewswire/ -- AdventHealth Tampa announced a new 20-bed unit dedicated to patients diagnosed with heart failure. The disease affects one in five people over age 40, according to the American Heart Association, and it's one of the most common reasons people over the age of 65 go to the hospital. In many cases, heart failure can be managed with advanced medical care, medications, and lifestyle changes. This new unit allows AdventHealth's board-certified cardiologists to provide advanced therapies and highly specialized care to patients who have the most progressed stages of the disease.

Key Points: 
  • The new unit at AdventHealth Tampa's Pepin Heart Institute allows cardiologists to provide advanced therapies that improve outcomes for patients.
  • TAMPA, Fla., March 8, 2023 /PRNewswire/ -- AdventHealth Tampa announced a new 20-bed unit dedicated to patients diagnosed with heart failure.
  • This new unit allows AdventHealth's board-certified cardiologists to provide advanced therapies and highly specialized care to patients who have the most progressed stages of the disease.
  • Gus Agocha, JaMia Washington, Oliver Abela, Rozales Swanson and Merna Armanious are leading the heart failure program for patients at AdventHealth Tampa.

First Patient in Minnesota Receives TG Therapeutics' New Multiple Sclerosis Drug at Infusion Associates Outpatient Infusion Center

Retrieved on: 
Wednesday, March 8, 2023
Fatigue, Multiple sclerosis, Insurance, Brain, Patient, MS, RMS, Person, Hypoesthesia, Medicine, Central nervous system, Therapy, Quality of life, Disability, Weakness, Minnesota Center for Book Arts, FDA, Conditional sentence, TG, Medical device, Pharmaceutical industry, Ublituximab

PLYMOUTH, Minn., March 8, 2023 /PRNewswire/ -- Infusion Associates (IA), one of the Midwest's leading providers of medically prescribed outpatient infusion and injection therapies, completed their first Briumvi™ (ublituximab-xiiy) infusion treatment for a patient at their Plymouth, Minnesota location.

Key Points: 
  • PLYMOUTH, Minn., March 8, 2023 /PRNewswire/ -- Infusion Associates (IA), one of the Midwest's leading providers of medically prescribed outpatient infusion and injection therapies, completed their first Briumvi™ (ublituximab-xiiy) infusion treatment for a patient at their Plymouth, Minnesota location.
  • Infusion Associates is the first healthcare facility in Minnesota to administer the new FDA approved drug treating multiple sclerosis (MS).
  • Multiple sclerosis is a chronic disease that impacts the central nervous system, disrupting the flow of information within the brain and between the brain and body.
  • Infusion Associates' leading clinical team has been caring for patients with chronic illnesses, including multiple sclerosis, through infusion and injection treatments for over 20 years.

BOTOX® Cosmetic (onabotulinumtoxinA) Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs

Retrieved on: 
Wednesday, March 8, 2023
Woman, Catherine Disher, Science, Medication, NYSE, Injection, Xerostomia, Partnership, Allergy, FAAD, International Women's Day, Senior, Weakness, Paratriathlon, Headache, ALS, Medical director, Risk, Official rules of Major League Baseball, MATCH International Women's Fund, AB toxin, Asthma, Vitamin, Fatigue, Myasthenia gravis, Wheeze, Rash, Skin infection, Dermatology, Breast milk, Lambert–Eaton myasthenic syndrome, Skin, ABBV, AbbVie, Growth, Success, Face, Neck pain, Hope, Human, Eyelid, Eyebrow, Pain, Dizziness, Management, Nursing, Pharmaceutical industry, Birth control, Canning, Cosmetics, Medical device, MD

IRVINE, Calif., March 8, 2023 /PRNewswire/ -- In honor of International Women's Day, Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced that BOTOX® Cosmetic is partnering with IFundWomen, the go-to funding marketplace for women-owned businesses, on a grant program. Women entrepreneurs can apply for the opportunity to receive one of 20 grants worth $25,000 each, as well as a year of coaching and mentorship to boost confidence, advance knowledge, and inspire action.

Key Points: 
  • The goal of the partnership is to help address the "Confidence Gap" among rising women entrepreneurs.
  • "Success depends as much on confidence as it does on competence," said Karen Cahn, Founder, and Chief Executive Officer of IFundWomen.
  • "Despite the many advancements women entrepreneurs have made because of their high levels of competence, the 'Confidence Gap' still very much exists.
  • With BOTOX® Cosmetic and IFundWomen, the opportunity for grants, coaching, and mentorship help make that path more straightforward for women entrepreneurs."

ADP National Employment Report: Private Sector Employment Increased by 242,000 Jobs in February; Annual Pay was Up 7.2%

Retrieved on: 
Wednesday, March 8, 2023
Growth, ADP, Weakness, National Employment Standards, Tutoring

ROSELAND, N.J., March 8, 2023 /PRNewswire/ -- Private sector employment increased by 242,000 jobs in February and annual pay was up 7.2 percent year-over-year, according to the February ADP® National Employment ReportTM produced by the ADP Research Institute® in collaboration with the Stanford Digital Economy Lab ("Stanford Lab").

Key Points: 
  • ROSELAND, N.J., March 8, 2023 /PRNewswire/ -- Private sector employment increased by 242,000 jobs in February and annual pay was up 7.2 percent year-over-year, according to the February ADP® National Employment ReportTM produced by the ADP Research Institute® in collaboration with the Stanford Digital Economy Lab ("Stanford Lab").
  • The jobs report and pay insights use ADP's fine-grained anonymized and aggregated payroll data of over 25 million U.S. employees to provide a representative picture of the labor market.
  • The report details the current month's total private employment change, and weekly job data from the previous month.
  • ADP's pay measure uniquely captures the earnings of a cohort of almost 10 million employees over a 12-month period.

Business Spend Software Market is Probable to Influence the Value of USD 31,398.60 Million by 2029, Size, Share, Trends, Growth and Competitive Outlook

Retrieved on: 
Wednesday, March 8, 2023
Spend, Software, Travel, Growth, Internet, Machine learning, Porter's five forces analysis, Weakness, Artificial intelligence, ML, SWOT analysis, Observation, Overalls, Risk management, Medical device, Retail, Video game, Online shopping

Business Spend Software Market Report Answers the Following Questions:

Key Points: 
  • Business Spend Software Market Report Answers the Following Questions:
    How much revenue will the Business Spend Software market generate by the end of the forecast period?
  • What are the main strategies of the major players in the Business Spend Software market to expand their geographic presence?
  • How do regulatory standards affect the Business Spend Software market?
  • To Gain More Insights About This Market Analysis, Visit @ https://www.databridgemarketresearch.com/reports/global-business-spend-s...
    Business Spend Software Market Segmentations:

Business Spend Software Market is Probable to Influence the Value of USD 31,398.60 Million by 2029, Size, Share, Trends, Growth and Competitive Outlook

Retrieved on: 
Wednesday, March 8, 2023
Spend, Software, Travel, Growth, Internet, Machine learning, Porter's five forces analysis, Weakness, Artificial intelligence, ML, SWOT analysis, Observation, Overalls, Risk management, Medical device, Retail, Video game, Online shopping

Business Spend Software Market Report Answers the Following Questions:

Key Points: 
  • Business Spend Software Market Report Answers the Following Questions:
    How much revenue will the Business Spend Software market generate by the end of the forecast period?
  • What are the main strategies of the major players in the Business Spend Software market to expand their geographic presence?
  • How do regulatory standards affect the Business Spend Software market?
  • To Gain More Insights About This Market Analysis, Visit @ https://www.databridgemarketresearch.com/reports/global-business-spend-s...
    Business Spend Software Market Segmentations:

Washington OSPI Recommends Curriculum Associates' i-Ready® as a Rapid Automatized Naming (RAN) Assessment for Early Screening of Dyslexia

Retrieved on: 
Tuesday, March 7, 2023
Literacy, Learning, RAN, LAP, Smarter Balanced Assessment Consortium, Student, Reading, Customer service, Superintendent, Weakness, Technical support, Letter, Diagnosis, Mathematics, OSPI, Curriculum, Management, Nursing, Tutoring, Washington State, Dyslexia

NORTH BILLERICA, Mass., March 7, 2023 /PRNewswire/ -- The Washington Office of Superintendent of Public Instruction (OSPI) recently named i-Ready's Rapid Automatized Naming (RAN) Literacy Tasks as a recommended RAN assessment for the early screening of dyslexia. Now, districts throughout Washington State can use the award-winning i-Ready program with its additional offline assessment tasks to identify indicators and areas of weakness that are highly predictive of future reading difficulty, including phonological awareness, phonemic awareness, letter sound knowledge, and rapid naming skills.

Key Points: 
  • NORTH BILLERICA, Mass., March 7, 2023 /PRNewswire/ -- The Washington Office of Superintendent of Public Instruction (OSPI) recently named i-Ready's Rapid Automatized Naming (RAN) Literacy Tasks as a recommended RAN assessment for the early screening of dyslexia.
  • "When screening for dyslexia, it is imperative that educators have a valid and reliable assessment such as i-Ready," said Rob Waldron, CEO of Curriculum Associates.
  • According to the Washington OSPI, the RAN assessment is a requirement of the early screening of dyslexia under E2SSB 6162-Early Screening of Dyslexia.
  • The recommended RAN assessment screens students' skills in rapid automatized naming and are required to include four assessment options, including colors, numbers, letters, and familiar objects.